CST3 and metabolic syndrome: At baseline, each 1 SD increment of cystatin C was significantly associated with an increased prevalence of MetS (adjusted for age and sex) (OR per 1 SD increment 1.36 (1.13–1.65), p = 0.001) (Table B in S1 File).